Italian Cohort of the Nivolumab EAP in Squamous NSCLC: Efficacy and Safety in Patients With CNS MetastasesDiego Cortinovis, Angelo Delmonte, Rita Chiari et al.|Anticancer Research|2019Cited by 38
Dose intensity and efficacy of the combination of everolimus and exemestane (EVE/EXE) in a real-world population of hormone receptor-positive (ER+/PgR+), HER2-negative advanced breast cancer (ABC) patients: a multicenter Italian experienceMariangela Ciccarese, Giammarco Surico, Laura Isabella Lupo et al.|Breast Cancer Research and Treatment|2017Cited by 12
Abstract P4-13-15: Dose intensity and efficacy of the combination of everolimus and exemestane (EVE/EXE) in a real world population of hormone receptor positive advanced breast cancer: A multicenter Italian experienceR. Forcignanò, Mariangela Ciccarese, Luciana Petrucelli et al.|Cancer Research|2016Cited by 0